Literature DB >> 19878866

Mst out and HCC in.

Bin Zhao1, Qunying Lei, Kun-Liang Guan.   

Abstract

Mst1 and Mst2 are key components of the Hippo tumor suppressor pathway. In this issue, Zhou et al. (2009) reported that Mst1/2 ablation leads to hepatocellular carcinomas. Unexpectedly, Mst1/2 may activate another kinase besides Lats1 and Lats2 to phosphorylate YAP, and the role of Mst1/2 in YAP regulation is cell type dependent.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19878866     DOI： 10.1016/j.ccr.2009.10.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  17 in total

1.  CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.

Authors:  Liu Lei; Jinsheng Wu; Dianhua Gu; Hui Liu; Shaochuang Wang
Journal:  Tumour Biol       Date:  2016-02-23

2.  E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.

Authors:  Nam-Gyun Kim; Eunjin Koh; Xiao Chen; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

3.  CIZ1 is upregulated in hepatocellular carcinoma and promotes the growth and migration of the cancer cells.

Authors:  Jinsheng Wu; Liu Lei; Dianhua Gu; Hui Liu; Shaochuang Wang
Journal:  Tumour Biol       Date:  2015-10-30

4.  MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.

Authors:  Lina Cheng; Hongwei Wang; Shuangyin Han
Journal:  Dig Dis Sci       Date:  2017-08-19       Impact factor: 3.199

5.  Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.

Authors:  Woojin Jeong; Sang-Bae Kim; Bo Hwa Sohn; Yun-Yong Park; Eun Sung Park; Sang Cheol Kim; Sung Soo Kim; Randy L Johnson; Michael Birrer; David S L Bowtell; Gordon B Mills; Anil Sood; Ju-Seog Lee
Journal:  Anticancer Res       Date:  2014-02       Impact factor: 2.480

6.  Regulatory effect of microRNA-223-3p on breast cancer cell processes via the Hippo/Yap signaling pathway.

Authors:  Tonghua Du; Dan Wang; Xiaoyu Wan; Jingwei Xu; Qi Xiao; Bin Liu
Journal:  Oncol Lett       Date:  2021-05-06       Impact factor: 2.967

7.  Sub-cellular localisation studies may spuriously detect the Yes-associated protein, YAP, in nucleoli leading to potentially invalid conclusions of its function.

Authors:  Megan L Finch; Adam M Passman; Robyn P Strauss; George C Yeoh; Bernard A Callus
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.

Authors:  Tian-Yi Zhou; Lin-Han Zhuang; Yan Hu; Yu-Lu Zhou; Wen-Kai Lin; Dan-Dan Wang; Zi-Qian Wan; Lin-Lin Chang; Ying Chen; Mei-Dan Ying; Zi-Bo Chen; Song Ye; Jian-Shu Lou; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

9.  Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells.

Authors:  X Zhang; X Liu; J Luo; W Xiao; X Ye; M Chen; Y Li; G-J Zhang
Journal:  Oncogenesis       Date:  2016-11-14       Impact factor: 7.485

10.  The hippo-yes association protein pathway in liver cancer.

Authors:  Lu Jie; Wang Fan; Dai Weiqi; Zhou Yingqun; Xu Ling; Shen Miao; Cheng Ping; Guo Chuanyong
Journal:  Gastroenterol Res Pract       Date:  2013-08-06       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.